Amarin Corp Plc (AMRN)

[jfmcrr]

You have been calling for RWE research on Vascepa for some time. Now when an actual study pops up

It'll always be a mixed bag. RWE will give you the big numbers and bespoke studies will give you maximal consideration of and design for isomorphism. I'm comfortable with calling REDUCE IT the first and last and biggest best study. The motivation, justification and money were there then. Now they're not.

Back inna day when I was a high end hifi manufacturer, I'd present the physiology of hearing and hearing pathology as per my wife's (MS Speech and Language Pathology) coaching at the CES. Audiophiles thought time and money should be spent by academia on their outta the way niche interests. I hadda laugh. Comparatively, Vascepa and heart health are of a much more critical nature to humanity. But operationally, the time and money allocated and spent give you a concrete measure of the priority given to it. So it goes.